These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33794090)

  • 1. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach.
    Seeberger PH
    Chem Rev; 2021 Apr; 121(7):3598-3626. PubMed ID: 33794090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic carbohydrate-based vaccines: challenges and opportunities.
    Mettu R; Chen CY; Wu CY
    J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
    Zasłona ME; Downey AM; Seeberger PH; Moscovitz O
    Biochem Soc Trans; 2021 Nov; 49(5):2411-2429. PubMed ID: 34495299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving vaccines against
    Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
    Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
    ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semisynthetic
    Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
    Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines.
    Javed ; Mandal PK
    Carbohydr Res; 2021 Apr; 502():108277. PubMed ID: 33743443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance.
    Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R
    Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Chemical Society - 229th National Meeting: carbohydrate vaccines.
    Rotella DP
    IDrugs; 2005 May; 8(5):387-9. PubMed ID: 15883917
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine.
    Oldrini D; Del Bino L; Arda A; Carboni F; Henriques P; Angiolini F; Quintana JI; Calloni I; Romano MR; Berti F; Jimenez-Barbero J; Margarit I; Adamo R
    Chemistry; 2020 Jun; 26(31):7018-7025. PubMed ID: 32058627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
    Khatun F; Stephenson RJ; Toth I
    Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against
    Ravinder M; Liao KS; Cheng YY; Pawar S; Lin TL; Wang JT; Wu CY
    J Org Chem; 2020 Dec; 85(24):15964-15997. PubMed ID: 33108196
    [No Abstract]   [Full Text] [Related]  

  • 13. A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.
    Parameswarappa SG; Reppe K; Geissner A; Ménová P; Govindan S; Calow ADJ; Wahlbrink A; Weishaupt MW; Monnanda BP; Bell RL; Pirofski LA; Suttorp N; Sander LE; Witzenrath M; Pereira CL; Anish C; Seeberger PH
    Cell Chem Biol; 2016 Nov; 23(11):1407-1416. PubMed ID: 27818299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
    Adamo R
    Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*.
    Zhang S; Sella M; Sianturi J; Priegue P; Shen D; Seeberger PH
    Angew Chem Int Ed Engl; 2021 Jun; 60(26):14679-14692. PubMed ID: 33852172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
    Berti F; Micoli F
    Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].
    Mulard L
    Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent mechanistic insights on glycoconjugate vaccines and future perspectives.
    Berti F; Adamo R
    ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR assays for carbohydrate-based vaccines.
    Jones C
    J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.